Australia's Imricor Medical Systems slips on discounted placement
04/05/2026 06:06
** Shares of Imricor Medical Systems IMR.AX fall as much as 6.3% to A$1.85, their lowest level since April 14 ** On track to mark worst session since April 22 ** Medical device developer receives firm commitments to raise A$60 million ($43.24 million) via placement ** Offer price of A$1.85 represents a 6.3% discount to its last close ** Proceeds will be used to accelerate Imricor’s growth strategy, including launching NorthStar in the U.S., and others, co says ** Up 22.6% YTD, including session's moves ($1 = 1.3877 Australian dollars) (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com; ))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion